General Information of the Compound
Compound ID
CP0479428
Compound Name
5-[5-[4-(1-methylpiperidin-4-yl)oxyphenyl]-8-oxo-6-sulfanylidene-5,7-diazaspiro[3.4]octan-7-yl]-3-(trifluoromethyl)pyridine-2-carbonitrile
    Show/Hide
Structure
Formula
C25H24F3N5O2S
Molecular Weight
515.561
Canonical SMILES
CN1CCC(CC1)Oc1ccc(cc1)N1C(=S)N(C(=O)C11CCC1)c1cnc(C#N)c(c1)C(F)(F)F
    Show/Hide
InChI
InChI=1S/C25H24F3N5O2S/c1-31-11-7-19(8-12-31)35-18-5-3-16(4-6-18)33-23(36)32(22(34)24(33)9-2-10-24)17-13-20(25(26,27)28)21(14-29)30-15-17/h3-6,13,15,19H,2,7-12H2,1H3
    Show/Hide
InChIKey
IZKSMIBPGSWAMO-UHFFFAOYSA-N
Physicochemical Property
logP
4.50588
Rotatable Bonds
4
Heavy Atom Count
36
Polar Areas
72.7
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
6
Complexity
36

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 86683482
ChEMBL ID
CHEMBL4865865
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00894, Androgen receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000141 LNCaP Homo sapiens (Human)  4
1
IC50 = 19 nM
   TI
   LI
   LO
   TS
2
IC50 = 98 nM
   TI
   LI
   LO
   TS
3
IC50 = 191 nM
   TI
   LI
   LO
   TS
4
Ki = 8.4 nM
   TI
   LI
   LO
   TS
CL000063 Hep-G2 Homo sapiens (Human)  1
1
IC50 = 127 nM
   TI
   LI
   LO
   TS
Protein ID: PT00967, Glucocorticoid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000228 IM-9 Homo sapiens (Human)  2
1
IC50 = 20000 nM
   TI
   LI
   LO
   TS
2
Ki = 9900 nM
   TI
   LI
   LO
   TS